Testing effectiveness (Phase 2)Ended earlyNCT03047837
What this trial is testing
A Randomized, 2x2 Factorial Design Biomarker Prevention Trial of Low-dose ASA and Metformin in Stage I-III Crc Patients
Who this might be right for
Tertiary Prevention in Colon Cancer
Ente Ospedaliero Ospedali Galliera 160